Pharmacokinetic analysis and anticonvulsant activity of glycine and glycinamide derivatives

By Sussan S.   Dagan A.   Bialer M.  

Epilepsy Research, Vol. 33, Iss. 1, 1999-01 ,pp. : 11-21

Elsevier

Access to resources Recommend Favorite

Assessment of teratogenic risk design and status of the North American antiepileptic drug registry

By Holmes L.B.   Pierce M.W.  

Epilepsy Research, Vol. 45, Iss. 1, 2001-05 ,pp. : 175-176

Elsevier

Access to resources Recommend Favorite

Kindling model: a tool for evaluating therapeutic and prophylactic effects of standard antiepileptic drugs and sulfonamide derivatives

By Hamada K.   Hiyoshi T.   Kudo T.   Nakamura F.   Song H.-K.   Ishida S.   Yagi K.   Seino M.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 67-67

Elsevier

Access to resources Recommend Favorite

Structural requirements of anti-GD1a antibodies determine their target specificity

By Lopez Pablo H. H.  

Brain, Vol. 131, Iss. 7, 2008-07 ,pp. : 1926-1939

Oxford University Press

Access to resources Recommend Favorite

Antiepileptic drugs in schizophrenia: a review

By Hosak L.   Libiger J.  

European Psychiatry, Vol. 17, Iss. 7, 2002-11 ,pp. : 371-378

Elsevier

Access to resources Recommend Favorite